Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 7 studies | 40% ± 12% | |
| ciliated cell | 5 studies | 25% ± 9% | |
| GABAergic neuron | 4 studies | 40% ± 17% | |
| glutamatergic neuron | 4 studies | 34% ± 14% | |
| microglial cell | 3 studies | 22% ± 4% | |
| astrocyte | 3 studies | 26% ± 8% | |
| interneuron | 3 studies | 32% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 37% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 98% | 34.24 | 177 / 180 | 21% | 0.36 | 89 / 430 |
| brain | 95% | 43.03 | 2518 / 2642 | 11% | 0.27 | 76 / 705 |
| thymus | 98% | 37.51 | 642 / 653 | 8% | 0.11 | 46 / 605 |
| uterus | 96% | 36.25 | 164 / 170 | 8% | 0.18 | 36 / 459 |
| breast | 78% | 17.75 | 357 / 459 | 23% | 0.40 | 260 / 1118 |
| adrenal gland | 90% | 21.48 | 232 / 258 | 9% | 0.12 | 20 / 230 |
| kidney | 83% | 18.38 | 74 / 89 | 12% | 0.17 | 105 / 901 |
| prostate | 90% | 15.78 | 220 / 245 | 2% | 0.04 | 12 / 502 |
| lung | 84% | 33.72 | 488 / 578 | 6% | 0.13 | 69 / 1155 |
| skin | 82% | 13.67 | 1486 / 1809 | 2% | 0.05 | 8 / 472 |
| pancreas | 77% | 9.91 | 254 / 328 | 3% | 0.07 | 6 / 178 |
| intestine | 78% | 14.28 | 753 / 966 | 0% | 0.01 | 2 / 527 |
| blood vessel | 77% | 12.75 | 1026 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 64% | 8.67 | 925 / 1445 | 2% | 0.02 | 3 / 183 |
| adipose | 65% | 10.80 | 784 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 62% | 6.71 | 13 / 21 | 2% | 0.04 | 11 / 504 |
| heart | 47% | 6.04 | 405 / 861 | 0% | 0 | 0 / 0 |
| stomach | 45% | 6.39 | 163 / 359 | 1% | 0.02 | 3 / 286 |
| spleen | 18% | 1.50 | 43 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 15% | 0.21 | 12 / 80 |
| liver | 12% | 0.89 | 27 / 226 | 0% | 0.00 | 1 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.11 | 2 / 29 |
| muscle | 4% | 0.35 | 32 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| peripheral blood | 2% | 0.25 | 19 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008150 | Biological process | biological_process |
| GO_0006096 | Biological process | glycolytic process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0000015 | Cellular component | phosphopyruvate hydratase complex |
| GO_0004634 | Molecular function | phosphopyruvate hydratase activity |
| GO_0000287 | Molecular function | magnesium ion binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | ENO4 |
| Protein name | phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) |
| Synonyms | C10orf134 |
| Description | FUNCTION: May be required for sperm motility and function. . |
| Accessions | A0A5H1ZRQ0 A6NNW6 ENST00000622726.4 ENST00000341276.11 [A6NNW6-3] ENST00000369207.3 ENST00000409522.5 [A6NNW6-2] A0A5H1ZRS3 |